Basic Information
ID: ALA3420264
Type: ADME
Description: Drug level in human liver microsomes treated with 5-(8-Fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole assessed as compound formation in presence of NADPH by LC-MS/MS method
Format: BAO_0000019
Organism: Homo sapiens
Tissue: Liver
Target: Liver microsome(ALA2367379)
Document: ALA3414463
Drug level in human liver microsomes treated with 5-(8-Fluoro-3-(1-(3-(2-methoxyethoxy)quinolin-6-yl)ethyl)-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-3-methylisoxazole assessed as compound formation in presence of NADPH by LC-MS/MS method: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3420264
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 433.44 | 3.90 | 3.90 |
| 447.43 | 4.00 | 4.00 |